Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société TAKEDA PHARMACEUTICAL COMPANY LIMITED
07:01aGENERAL ANNOUNCEMENT : :Takeda Provides Update on Status of Acquisition of Own Shares
PU
01:21aTAKEDA PHARMACEUTICAL : Provides Update on Status of Acquisition of Own Shares
PU
11/30Takeda Announces U.S. Corporate Social Responsibility (CSR) Program Aimed to Help Reduc..
BU
11/30GENERAL ANNOUNCEMENT : :The 145th Interim Business Report (April 1, 2021 - September 30, 2..
PU
11/30TAKEDA PHARMACEUTICAL : The 145th (interim period) Business Report
PU
11/24Takeda's LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment ..
AQ
11/23Takeda's LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment ..
BU
11/23TAKEDA PHARMACEUTICAL : LIVTENCITY (maribavir) Approved by U.S. FDA as the First and Only ..
PU
11/17Canadian Blood Services Awards Takeda Canada Three-Year Tender for Hemophilia treatment..
AQ
11/11Japan's Takeda applies for gov't approval of Moderna's booster shots
AQ
11/05Quarterly Securities Report(The second quarter of 145th Business Term) for The Six-mont..
PU
11/04Takeda Recommends Common-sense Policy Reforms Designed to Reduce Time to Diagnosis, Imp..
BU
11/01Takeda Applied for Selection of “Prime Market”, Filed Corporate Governance ..
PU
11/01Takeda Applied for Selection of “Prime Market”,  Filed Corporate Governance..
PU
11/01Takeda Applied for Selection of “Prime Market”, Filed Corporate Governance ..
BU
11/01I.Basic Views on Corporate Governance and Basic Information on Capital Structure, Corpo..
PU
10/28Update on the US Development Program for the Investigational Subcutaneous Formulation o..
PU
10/28Takeda Announces Acquisition of Own Shares - Form 6-K
PU
10/28Summary of Financial Statements for the Six-month Period Ended September 30, 2021 (IFRS..
PU
10/28Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic T Cel..
AQ
10/28GENERAL ANNOUNCEMENT : :Takeda Announces Acquisition of Own Shares
PU
10/28Takeda Delivers Strong H1 FY2021 Results; Further Growth Momentum Expected Through Fisc..
PU
10/28Takeda Announces Acquisition of Own Shares
PU
10/27Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic Cell ..
PU
10/27Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic &gamm..
BU
10/21TAKEDA PHARMACEUTICAL : to Hold Second Quarter FY2021 Earnings Conference Calls
PU
10/13TAKEDA PHARMACEUTICAL : BioLife Plasma Services Announces Expansion of Plasma Donation Cen..
BU
10/08TAKEDA PHARMACEUTICAL : - FDA Advisory Committee Recommends Use of Investigational Drug Ma..
AQ
10/08TAKEDA PHARMACEUTICAL : NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART,..
PU
10/07GENERAL ANNOUNCEMENT : :Takeda Sets Terms and Conditions for its 10-Year Yen Denominated U..
PU
10/07TAKEDA PHARMACEUTICAL : Sets Terms and Conditions for its 10-Year Denominated Unsecured Se..
PU
10/07TAKEDA PHARMACEUTICAL : Sets Terms and Conditions for its 10-Year Yen Denominated Unsecure..
PU
10/07TAKEDA PHARMACEUTICAL : FDA Advisory Committee Recommends Use of Investigational Drug Mari..
PU
10/07TAKEDA PHARMACEUTICAL : FDA Advisory Committee Recommends Use of Investigational Drug Mari..
BU
10/06TAKEDA PHARMACEUTICAL : How your plasma can help those with life-threatening diseases
AQ
10/06TAKEDA PHARMACEUTICAL : Provides Update on TAK-994 Clinical Program (Form 6-K)
PU
10/05TAKEDA PHARMACEUTICAL : Provides Update on TAK-994 Clinical Program
BU
10/01TAKEDA PHARMACEUTICAL : STATEMENT REGARDING MODERNA COVID-19 VACCINE RECALL INVESTIGATION ..
PU
09/30TAKEDA PHARMACEUTICAL : Statement regarding Moderna COVID-19 Vaccine Recall Investigation ..
PU
09/30TAKEDA PHARMACEUTICAL : to Commercialize Next-Generation Hunter Syndrome Therapy Through C..
BU
09/29TAKEDA PHARMACEUTICAL : Seramount Names Takeda as One of the 2021 100 Best Companies and B..
AQ
09/28TAKEDA PHARMACEUTICAL : Seramount names takeda as one of the 2021 100 best companies and b..
PU
09/28TAKEDA PHARMACEUTICAL : Receives Approval to Manufacture and Market Alofisel? (darvadstroc..
AQ
09/27TAKEDA PHARMACEUTICAL : Receives Approval to Manufacture and Market Alofisel®▼ (darv..
PU
09/23TAKEDA PHARMACEUTICAL : WFP and Takeda deepen partnership in West Africa to strengthen hea..
AQ
09/22TAKEDA PHARMACEUTICAL : Breaks Ground on its First Zero Energy Building in Singapore
PU
09/22TAKEDA PHARMACEUTICAL : WFP and Takeda deepen partnership in West Africa to strengthen hea..
AQ
09/22TAKEDA PHARMACEUTICAL : Selects Four New Partners for Annual Global Corporate Social Respo..
BU
09/21TAKEDA PHARMACEUTICAL : Mirum Pharmaceuticals and Takeda Enter into Exclusive Licensing Ag..
BU
09/16TAKEDA PHARMACEUTICAL : Continues to Advance Growth Strategy with Sale Of Non-Core Assets ..
PU
09/16TAKEDA PHARMACEUTICAL : EXKIVITY (mobocertinib) Approved by U.S. FDA as the First Oral The..
AQ
09/16THERMO FISHER SCIENTIFIC : FDA Approves Tissue-Based NGS Companion Diagnostic for Takeda's..
AQ
09/15TAKEDA PHARMACEUTICAL : EXKIVITY™ (mobocertinib) Approved by U.S. FDA as the First O..
BU
09/13TAKEDA PHARMACEUTICAL : Novavax Statement on Takeda Agreement to Provide 150 Million Doses..
AQ
09/07TAKEDA PHARMACEUTICAL : Response to the New Incident Announced by the Japanese Ministry of..
PU
09/07TAKEDA PHARMACEUTICAL : to Manufacture and Provide 150 Million Doses of Novavax' COVID-19 ..
PU
09/06TAKEDA PHARMACEUTICAL : to Manufacture and Provide 150 Million Doses of Novavax' COVID-19 ..
PU
09/06GENERAL ANNOUNCEMENT : :Takeda Response to the New Incident Announced by the Japanese MHLW..
PU
09/06TAKEDA PHARMACEUTICAL : to Manufacture and Provide 150 Million Doses of Novavax' COVID-19 ..
PU
09/06TAKEDA PHARMACEUTICAL : Response to the New Incident Announced by the Japanese MHLW
PU
09/03TAKEDA PHARMACEUTICAL : Building on research to bring innovation to patients
PU
09/01TAKEDA PHARMACEUTICAL : Provides Update on Phase 3 PANTHER (Pevonedistat-3001) Trial
BU
09/01GENERAL ANNOUNCEMENT : :Joint Statement from Moderna and Takeda: Investigation of Suspende..
PU
09/01TAKEDA PHARMACEUTICAL : Joint Statement from Moderna and Takeda on the Investigation of Su..
PU
09/01TAKEDA PHARMACEUTICAL : Joint Statement from Moderna and Takeda on the Investigation of Su..
PU
08/30GENERAL ANNOUNCEMENT : :Moderna and Takeda Response to the Incidents Announced by the Japa..
PU
08/30TAKEDA PHARMACEUTICAL : Moderna and Takeda's Response to the Incidents Announced by the Ja..
PU
08/30TAKEDA PHARMACEUTICAL : Moderna and Takeda's Response to the Incidents Announced by the Ja..
PU
08/27TAKEDA PHARMACEUTICAL : Notice of Suspension of Use of Specific Lots of Moderna's COVID-19..
PU
08/27TAKEDA PHARMACEUTICAL : Notice of Suspension of Use of Specific Lots of Moderna's COVID-19..
PU
08/26Exelixis Announces Partner Takeda and Ono Receive Approval in Japan for CABOMETYX (cabo..
AQ
08/26MODERNA : Japan shelves 1.6M tainted doses of Moderna COVID-19 vaccine
AQ
08/25URGENT : Unused Moderna vaccine doses may contain foreign materials: Japan
AQ
08/18TAKEDA PHARMACEUTICAL : BioLife Plasma Services Opens First All-Electric Plasma Donation C..
BU
08/18GENERAL ANNOUNCEMENT : :Articles of Incorporation
PU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on TAKEDA PHARMACEUTICAL COMPANY LIMITED